An interesting study, suggesting that cancer stem cells are known to mediate metastasis and recurrence and are therefore a promising therapeutic target, is focused on the CSC inhibitory effect of dihydrotanshinone (DHTS) that involves NOX5 activation. This evidence concerns the gene NOX5 and cancer.